U
BMY icon

UBS’s Bristol-Myers Squibb BMY Stock Holding History

UBS’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$16.3M Buy
319,076
+227,343
+248% +$11.4M 0.01% 1083
2014
Q2 		$4.45M Sell
91,733
-201,667
-69% -$9.94M ﹤0.01% 2073
2014
Q1 		$15.2M Buy
293,400
+228,800
+354% +$12.2M 0.01% 962
2013
Q4 		$3.43M Sell
64,600
-106,600
-62% -$5.43M ﹤0.01% 2240
2013
Q3 		$7.92M Buy
171,200
+58,500
+52% +$2.57M 0.01% 1309
2013
Q2 		$5.04M Buy
+112,700
New +$4.89M 0.01% 1610

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS's BMY Position: Q3 2014 in Review

UBS reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q3 2014, selling an estimated $4.52M and leaving 4,410,007 shares worth $226M. The position accounts for 0.17% of the portfolio, ranked #133.

UBS first reported a position in BMY in Q2 2013 and has held it in 6 quarters since. The position peaked at $261M in Q1 2014. 1,302 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

  • UBS held 4,410,007 shares of Bristol-Myers Squibb worth $226M as of Q3 2014.
  • UBS sold 90,453 Bristol-Myers Squibb shares in Q3 2014, an estimated $4.52M.
  • Bristol-Myers Squibb made up 0.17% of UBS's portfolio in Q3 2014, its #133 holding.
  • UBS first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 6 quarters since.
  • UBS's Bristol-Myers Squibb position peaked at $261M in Q1 2014.
  • 1,302 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.